GRAM CAR CARRIERS And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – GRAM CAR CARRIERS (GCC.OL), SALMAR (SALM.OL), BOIRON (BOI.PA) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. GRAM CAR CARRIERS (GCC.OL)

81% sales growth and 19.55% return on equity

Gram Car Carriers ASA, through its subsidiaries, operates as a tonnage supplier worldwide. The company invests in and operates assets in the pure car and truck carrier shipping segment. It provides a fleet of vessels for various aspects of the seaborne vehicle transportation trade. The company also offers commercial management services for the 18 owned vehicles and 4 managed vessels owned by third parties. Gram Car Carriers ASA was founded in 2006 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, GRAM CAR CARRIERS has a trailing twelve months EPS of kr0.28.

PE Ratio

GRAM CAR CARRIERS has a trailing twelve months price to earnings ratio of 542.01. Meaning, the purchaser of the share is investing kr542.01 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.55%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Mar 3, 2023, the estimated forward annual dividend rate is 4.19 and the estimated forward annual dividend yield is 2.74%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 73.4%, now sitting on 120.98M for the twelve trailing months.

Yearly Top and Bottom Value

GRAM CAR CARRIERS’s stock is valued at kr150.68 at 06:20 EST, way below its 52-week high of kr206.00 and way higher than its 52-week low of kr80.01.

2. SALMAR (SALM.OL)

45.8% sales growth and 18.21% return on equity

SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, the United States, Canada, Norway, rest of Europe, and internationally. It is involved in the broodfish, lumpfish, and smolt production activities; and marine-phase farming, harvesting, packaging, processing, and selling farmed salmon. The company sells its products to importers/exporters, processing companies, and retail chains through in-house sales force and/or through partners. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.

Earnings Per Share

As for profitability, SALMAR has a trailing twelve months EPS of kr17.49.

PE Ratio

SALMAR has a trailing twelve months price to earnings ratio of 23.89. Meaning, the purchaser of the share is investing kr23.89 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.

Moving Average

SALMAR’s worth is under its 50-day moving average of kr426.33 and way under its 200-day moving average of kr490.65.

Revenue Growth

Year-on-year quarterly revenue growth grew by 37.5%, now sitting on 20.07B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SALMAR’s EBITDA is 43.28.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 9, 2022, the estimated forward annual dividend rate is 20 and the estimated forward annual dividend yield is 4.88%.

3. BOIRON (BOI.PA)

17.3% sales growth and 9.87% return on equity

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Earnings Per Share

As for profitability, BOIRON has a trailing twelve months EPS of €2.86.

PE Ratio

BOIRON has a trailing twelve months price to earnings ratio of 14.3. Meaning, the purchaser of the share is investing €14.3 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 1, 2022, the estimated forward annual dividend rate is 0.95 and the estimated forward annual dividend yield is 2.28%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 35.2%, now sitting on 522.03M for the twelve trailing months.

Yearly Top and Bottom Value

BOIRON’s stock is valued at €40.90 at 06:20 EST, way below its 52-week high of €53.20 and higher than its 52-week low of €37.30.

4. ROBERTET (RBT.PA)

14.1% sales growth and 14.34% return on equity

Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in three segments: Raw materials, Fragrances, and Flavors. It also produces organic essential oils and active ingredients. The company operates in North America, Europe, the Asia Pacific, South America, Caribbean, Africa, and the Middle East. Robertet SA was founded in 1850 and is headquartered in Grasse, France.

Earnings Per Share

As for profitability, ROBERTET has a trailing twelve months EPS of €21.87.

PE Ratio

ROBERTET has a trailing twelve months price to earnings ratio of 39.55. Meaning, the purchaser of the share is investing €39.55 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.

Sales Growth

ROBERTET’s sales growth is 14.1% for the current quarter and 14.1% for the next.

5. ITERA (ITERA.OL)

11.2% sales growth and 138.07% return on equity

Itera ASA, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in Norway, Denmark, and Slovakia. It offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. The company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. Itera ASA was founded in 1989 and is based in Oslo, Norway.

Earnings Per Share

As for profitability, ITERA has a trailing twelve months EPS of kr0.49.

PE Ratio

ITERA has a trailing twelve months price to earnings ratio of 25. Meaning, the purchaser of the share is investing kr25 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 138.07%.

6. SPAREBANK 1 SMN (MING.OL)

9.7% sales growth and 11.54% return on equity

SpareBank 1 SMN, together with its subsidiaries, provides various banking, accounting, and real estate products and services to private individuals and companies in Norway and internationally. The company offers mortgage, car, boat, other vehicles, and consumer loans; refinancing; and current, savings, billing, business, group, tax deduction, currency, and deposit accounts. It also provides BSU house savings for young people; fixed interest deposits; stocks and investments; cash services; and payments. In addition, the company offers vehicle, housing and travel, person, animal, and valuables insurance services; property buying and selling advisory services; and mobile and online banking, and various cards. Further, it offers loans and financing, including bank guarantees, business and construction loans, operating credit for agriculture, factoring, guarantees, leasing, and overdrafts; various pension products; and business and personal insurance products. Additionally, the company provides document collection, letter of credit, future business, and currency option services; and services, including accounting and payroll, HR, taxes and duties, and transfer of ownership, as well as IT solutions. It offers real estate agency, advisory, and external and equity financing services. SpareBank 1 SMN was founded in 1823 and is headquartered in Trondheim, Norway.

Earnings Per Share

As for profitability, SPAREBANK 1 SMN has a trailing twelve months EPS of kr8.87.

PE Ratio

SPAREBANK 1 SMN has a trailing twelve months price to earnings ratio of 13.78. Meaning, the purchaser of the share is investing kr13.78 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.54%.

7. DASSAULT SYSTEMES (DSY.PA)

6% sales growth and 13.74% return on equity

Dassault Systèmes SE provides software solutions and services worldwide. It offers SOLIDWORKS design software for 3D design, electrical and printed circuit board design, product data management, simulation, manufacturing, and technical communication; CATIA, an engineering and design software for product 3D computer-aided design; GEOVIA for modeling and simulating the earth; and BIOVIA that provides the scientific community with advanced biological, chemical, and materials experiences. The company also provides SIMULIA that delivers realistic simulation applications; DELMIA, which enables global industrial operations; 3DVIA that provides 3D space planning solutions; and ENOVIA that enables to plan and track the definition of success for customer. In addition, it offers Centric PLM, a product lifecycle management software solution; 3DEXCITE, a real-time 3D visualization software; NETVIBES, which enables organizations to gather, align, and enrich big data; 3DEXPERIENCE platform that provides organizations a holistic and real-time view of their business activities and ecosystem, as well as connecting people, ideas, data, and solutions together in a single environment; and MEDIDATA, a clinical research study software that provides evidences and insights to pharmaceutical, biotech, medical device, and diagnostic companies, as well as academic researchers. Further, the company provides consulting, deployment, outcome based, and training services. It primarily serves companies in the transportation and mobility; industrial equipment; aerospace and defense; high-tech; life sciences and healthcare; energy and materials; home and lifestyle; construction, cities, and territories; consumer packaged goods and retail; marine and offshore; and business services sectors through distributors and resellers. Dassault Systèmes SE was incorporated in 1981 and is headquartered in Vélizy-Villacoublay, France.

Earnings Per Share

As for profitability, DASSAULT SYSTEMES has a trailing twelve months EPS of €0.63.

PE Ratio

DASSAULT SYSTEMES has a trailing twelve months price to earnings ratio of 60.32. Meaning, the purchaser of the share is investing €60.32 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.74%.

Volume

Today’s last reported volume for DASSAULT SYSTEMES is 511918 which is 60.97% below its average volume of 1311760.

Moving Average

DASSAULT SYSTEMES’s worth is above its 50-day moving average of €36.36 and higher than its 200-day moving average of €36.57.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on May 29, 2023, the estimated forward annual dividend rate is 0.17 and the estimated forward annual dividend yield is 0.46%.

Sales Growth

DASSAULT SYSTEMES’s sales growth is 9.3% for the current quarter and 6% for the next.

Leave a Reply

Your email address will not be published. Required fields are marked *